NINDS Advisory Council Agenda - September 4-5, 2019

NINDS Advisory Council Agenda - September 4-5, 2019

National Advisory Neurological Disorders and Stroke Council

206th Meeting

September 4-5, 2019

Building 35A, John Edward Porter Neuroscience Research Center
Conference Room 620/630/640
35 Convent Drive
Bethesda, Maryland 20892

NIH Videocast Website: http://videocast.nih.gov/

AGENDA

September 4, 2019

OPEN SESSION

12:30 p.m.

I.  Call to Order and Opening Remarks
       Dr. Walter Koroshetz, Chairperson, Director, NINDS

12:35 p.m.

II.  Report of the Director, Division of Extramural Activities, NINDS
       Dr. Robert Finkelstein

       A. Consideration of Minutes of May 23-24, Meeting

       B. Confirmation of Dates for Future Council Meetings            

                                                Wed. & Thurs., February 5-6, 2020                    

                                                Wed. & Thurs., May 27-28, 2020

                                                Wed. & Thurs., September 9-10, 2020                                                  

                                                Wed. & Thurs., February 10-11, 2021                 

                                                Wed. & Thurs., May 26-27, 2021                   

                                                Wed. & Thurs., September 8-9, 2021                                                                                         

       C.   Other Items

                          Expedited Review Process

                          Extramural Announcements

12:45 p.m.

III.  Report of the Director, NINDS
       Dr. Walter Koroshetz

1:05 p.m.

IV.  Discussion of Director’s Report

1:20 p.m.

V.  ME/CFS Working Group Report to Council
     Dr. Andrew Breeden, Health Program Specialist, NINDS
     Dr. Steven Roberds, Chief Scientific Officer, Tuberous Sclerosis Alliance

2:05 p.m.

VI. 2019 ADRD Summit Report
     Dr. Rod Corriveau, Program Director, NINDS
     Dr. Julie Schneider, The Deborah R. And Edgar D. Jannotta Presidential Professor of Pathology and Neurological Sciences,
          Associate Director, Rush Alzheimer's Disease Center, Rush University Medical Center

2:45 p.m. 

BREAK

3:00 p.m.

VII. Update from the Scientific Director of Intramural Research
        Dr. Lorna Role, Scientific Director, NINDS

 

4:00 p.m.

VIII. NINDS Early Stage Investigator Analysis
        Dr. William Daley, Health Program Specialist, NINDS

4:30 p.m.

IX. Initiatives Requiring Concept Clearance 

6:00 p.m. **

ADJOURNMENT

 

September 5, 2019

8:30 a.m.

CLOSED SESSION

This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

X.  Review of Conflict of Interest, Confidentiality, and Council Procedures
      Council Consideration of Pending Applications
      Dr. Robert Finkelstein, Executive Secretary, NANDS Council

This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

XI.  Review of the Division of Intramural Research Board of Scientific Counselors' Reports
       Dr. Walter Koroshetz

1:00 p.m. **

ADJOURNMENT
** This time is tentative